Investigating a new treatment pathway for bladder issues in aging men
Nitric Oxide-Soluble Guanylate Cyclase Pathway as a Target for Male Bladder Outlet Obstruction and Lower Urinary Tract Symptoms in Aging
This study is looking at how a specific pathway in the body can help improve treatment for men dealing with bladder issues caused by an enlarged prostate, especially as they get older, and aims to find new options that work better and have fewer side effects.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10910129 on NIH RePORTER |
What this research studies
This research focuses on understanding how the nitric oxide-soluble guanylate cyclase pathway can be targeted to improve treatment for men suffering from bladder outlet obstruction and lower urinary tract symptoms due to benign prostatic hyperplasia. The study aims to explore the underlying mechanisms of these conditions, particularly in aging populations, and evaluate new therapeutic options that may be more effective and have fewer side effects than current treatments. By examining the role of nitric oxide in bladder function, the research seeks to identify innovative strategies to alleviate symptoms and improve quality of life for affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are aging men experiencing bladder outlet obstruction or lower urinary tract symptoms related to benign prostatic hyperplasia.
Not a fit: Patients who are not experiencing bladder outlet obstruction or lower urinary tract symptoms, or those who are not male, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for bladder outlet obstruction and urinary symptoms, enhancing the quality of life for many aging men.
How similar studies have performed: Previous research has shown promise in targeting similar pathways for treating urinary symptoms, indicating potential for success in this novel approach.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Kanai, Anthony John — University of Pittsburgh at Pittsburgh
- Study coordinator: Kanai, Anthony John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.